Compound Detail
CHEMBL1206245
BRICICLIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1206245 |
| Name | BRICICLIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | LXENKEWVEVKKGV-BQYQJAHWSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
4
Publications
5
Known Names
1
Indications
1
Mechanisms
Molecular Properties
474.4
MW (Da)
2.78
ALogP
8
HBA
2
HBD
137.8
PSA (Ų)
0.49
QED
0
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| G1/S-specific cyclin D1 inhibitor | INHIBITOR | G1/S-specific cyclin-D1 | ✓ | ✓ |
Indications
Neoplasms
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine